1999
DOI: 10.1046/j.1365-2516.1999.00301.x
|View full text |Cite
|
Sign up to set email alerts
|

Spinal epidural haematoma in haemophilia A with inhibitors – efficacy of recombinant factor VIIa concentrate

Abstract: We report the case of a 21-year-old man with severe haemophilia A and factor VIII inhibitors who presented with an extensive spinal epidural haematoma (C2-T12), probably induced by sit-up exercises. The bleed was defined by magnetic resonance imaging of the cervical and thoracic spine and prompt treatment with recombinant factor VIIa concentrate led to complete resolution at 4 weeks. Neurological sequelae were averted and surgical decompression was not necessary. We discuss the difficulties in diagnosis and ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 11 publications
0
9
0
Order By: Relevance
“…The etiology of SSEH is generally unknown. Some predisposing factors include anticoagulant therapy [4], vascular malformation [5], hemophilia [6] and cocaine abuse [7], all suggested to be correlated with SSEH.…”
Section: Discussionmentioning
confidence: 99%
“…The etiology of SSEH is generally unknown. Some predisposing factors include anticoagulant therapy [4], vascular malformation [5], hemophilia [6] and cocaine abuse [7], all suggested to be correlated with SSEH.…”
Section: Discussionmentioning
confidence: 99%
“…2 Only a few reports have described SEHs in hemophiliac children with inhibitors. Leach et al 3 successfully treated a 21-year-old man with severe hemophilia A and inhibitors who presented with an extensive SEH using recombinant activated factor VIIa. Oymak et al 4 also successfully treated an infant with severe hemophilia A and inhibitors who presented with an SEH using recombinant activated factor VIIa.…”
Section: Discussionmentioning
confidence: 99%
“…During the early stages of bleeding, absolute resting is essential and slow mobilization is recommended in the following days. Prothrombin complex concentrates (PCC), aPCC and recombinant FVIIa are alternative therapy choices in patients with inhibitor [12].…”
Section: Discussionmentioning
confidence: 99%